Abstract: A pharmaceutical formulation, adapted for oral administration, wherein the pharmaceutical formulation comprises at least 1 000 IU, preferably of from 5 000 to 400 000 IU of a Vitamin D, per dosage form, and wherein the pharmaceutical formulation comprises, or consists of, an aqueous dispersion of micelles encapsulating said Vitamin D, and wherein the micelles are formed of, and essentially consist of, a tocopherol polyalkylene glycol such as D-?-tocopherol polyethylene glycol succinate.
Type:
Application
Filed:
March 17, 2022
Publication date:
April 18, 2024
Applicant:
SOLMIC BIOTECH GMBH
Inventors:
Marcus FURCH, Karen F. W. BESECKE, Helge DINKLER, Michael MACZKA